MARÍA AZUCENA
ESPARIS OGANDO
Investigadora en el periodo 1995-1996
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (7)
2024
-
ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression
International Journal of Molecular Sciences, Vol. 25, Núm. 6
2023
-
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications
Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257
2021
-
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
npj Precision Oncology, Vol. 5, Núm. 1
2020
-
Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer
Cancer Letters, Vol. 491, pp. 50-59
2019
-
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1
-
MEK5 promotes lung adenocarcinoma
The European respiratory journal
2016
-
Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies
Oncotarget, Vol. 7, Núm. 29, pp. 45042-45051